表紙
市場調查報告書
商品編碼
1040579

腦瘤治療藥市場:各適應症,各治療類型,各銷售管道,各地區:市場規模,佔有率,展望,機會分析(2021年∼2028年)

Brain Cancer Therapeutics Market, by Indication, by Treatment Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 190 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球腦瘤治療藥的市場規模,由於新藥的銷售和法規當局的認證增加,在預測期間中預計促進成長。

腦瘤的治療計劃,按照一定的要素,由專門研究腦腫瘤的醫生為每位患者設立。治療方法,根據癌症的種類,腫瘤的腦內位置,腫瘤的大小,患者的年齡和一般的健康狀態等大幅相同。還有治療計劃的大部分,根據患者的希望決定。

本報告提供腦瘤治療藥的世界市場調查,市場展望,各適應症、各治療類型、各銷售管道、各地區的市場分析,競爭情形,市場佔有率分析等資訊。

目錄

第1章 調查目的、前提條件

第2章 市場展望

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
    • 市場概述:各適應症
    • 市場概述:各治療類型
    • 市場概述:各銷售管道
    • 市場概述:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 開發平台分析
  • 法規概要
  • 市場趨勢
  • 主要的開發
  • 流行病學
  • PEST分析
  • 品牌分析

第4章 全球腦瘤治療藥市場:新型冠狀病毒(COVID-19)大流行的影響

  • 經濟影響
  • 臨床試驗和醫藥品開發的影響
  • 政府舉措

第5章 全球腦瘤治療藥市場:各適應症(2017年∼2028年)

  • 概要
  • 神經膠質母細胞瘤
  • 腦膜瘤
  • 下垂體腫瘤
  • 其他

第6章 全球腦瘤治療藥市場:各治療類型,2017年∼2028年,(US$Mn)

  • 概要
  • 標靶治療
  • 化療
  • 免疫療法
  • 其他

第7章 全球腦瘤治療藥市場:各銷售管道(2017年∼2028年)

  • 概要
  • 醫院藥局
  • 零售藥局

第8章 全球腦瘤治療藥市場:各地區(2017年∼2028年)

  • 概要
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭情形

  • 熱圖分析
  • 市場佔有率分析
    • Amgen Inc.
    • AstraZeneca PLC
    • F. Hoffmann-La Roche Ltd.
    • Pfizer Inc.
    • GlaxoSmithKline PLC
    • Novartis AG
    • Johnson & Johnson
    • Merck & Co
    • Bayer AG
    • Bristol-Myers Squibb Company
  • 分析師的見解

第10章 Section

目錄
Product Code: CMI4769

Cancer is one of the most prevalent and fatal chronic disorders with a high mortality rate. Throughout our lives, healthy cells in our bodies divide and replace themselves in a controlled fashion. Cancer starts when a cell is altered and it multiplies out of control. A tumor is formed when such abnormal cells grow to form a mass. Cancer cells grow to form tumor that interfere with brain functions such as muscle control, memory, sensation, and other normal bodily functions. Symptoms of brain cancer vary but often include weakness, difficulty walking, dizziness, seizures, and headaches.

The brain and spinal column make up the central nervous system (CNS), where all important functions are controlled. These functions include thought, body movements, and speech. This means that when a tumor grows in the CNS, it can affect a person's thought processes or the way they move or talk. A treatment plan is individualized and planned for each brain cancer patient depending on certain factors. The treatment plan is constructed by the doctors who are specialized in brain cancer, and treatments vary widely depending on the type of cancer, brain location of the tumor, tumor size, patient age, and the general health status of the patient. A major part of the plan is also determined by the wish of the patient.

Market Dynamics

The increasing launches of new drugs and regulatory approvals for brain cancer therapeutics are expected to drive the market growth during the forecast period. For instance, in June 2020, Food and Drug Administration (FDA) has granted fast track designation to TVAX Biomedical, Inc. for TVI-Brain-1, an adoptive T cell therapy for the treatment of glioblastoma multiforme. TVI-Brain-1 (TVAX Biomedical) is an autologous, vaccine-enhanced adoptive T-cell therapy consisting a proprietary vaccine pretreatment to create cancer-specific T cells and an activated antitumor T-cell treatment. The Fast Track Designation was supported by positive Phase 2 clinical data in addition to extensive preclinical and Phase 1 safety studies.

Key features of the study:

  • This report provides an in-depth analysis of the global brain cancer therapeutics market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global brain cancer therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Amgen Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Pfizer Inc., GlaxoSmithKline PLC, Novartis AG, Johnson & Johnson, Merck & Co, Bayer AG, and Bristol-Myers Squibb Company
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global brain cancer therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global brain cancer therapeutics market

Detailed Segmentation:

  • Global Brain Cancer Therapeutics Market, By Indication:
    • Glioblastoma
    • Meningioma
    • Pituitary Tumors
    • Others
  • Global Brain Cancer Therapeutics Market, By Treatment Type:
    • Targeted Therapy
    • Chemotherapy
    • Immunotherapy
    • Others
  • Global Brain Cancer Therapeutics Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Brain Cancer Therapeutics Market, By Region:
    • North America
      • Indication
      • Glioblastoma
      • Meningioma
      • Pituitary Tumors
      • Others
      • Treatment Type
      • Targeted Therapy
      • Chemotherapy
      • Immunotherapy
      • Others
      • Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • U.S.
      • Canada
    • Latin America
      • Indication
      • Glioblastoma
      • Meningioma
      • Pituitary Tumors
      • Others
      • Treatment Type
      • Targeted Therapy
      • Chemotherapy
      • Immunotherapy
      • Others
      • Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • Indication
      • Glioblastoma
      • Meningioma
      • Pituitary Tumors
      • Others
      • Treatment Type
      • Targeted Therapy
      • Chemotherapy
      • Immunotherapy
      • Others
      • Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • Indication
      • Glioblastoma
      • Meningioma
      • Pituitary Tumors
      • Others
      • Treatment Type
      • Targeted Therapy
      • Chemotherapy
      • Immunotherapy
      • Others
      • Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • Indication
      • Glioblastoma
      • Meningioma
      • Pituitary Tumors
      • Others
      • Treatment Type
      • Targeted Therapy
      • Chemotherapy
      • Immunotherapy
      • Others
      • Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • Indication
      • Glioblastoma
      • Meningioma
      • Pituitary Tumors
      • Others
      • Treatment Type
      • Targeted Therapy
      • Chemotherapy
      • Immunotherapy
      • Others
      • Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Amgen Inc.
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • AstraZeneca PLC
    • F. Hoffmann-La Roche Ltd.
    • Pfizer Inc.
    • GlaxoSmithKline PLC
    • Novartis AG
    • Johnson & Johnson
    • Merck & Co
    • Bayer AG
    • Bristol-Myers Squibb Company

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Indication
    • Market Snapshot, By Treatment Type
    • Market Snapshot, Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunity
  • Impact Analysis
  • Pipeline Analysis
  • Regulatory Scenario
  • Market Trends
  • Key Developments
  • Epidemiology
  • PEST Analysis
  • Brand Analysis

4. Global Brain Cancer Therapeutics Market- Impact of Coronavirus (COVID-19) Pandemic

  • Economic Impact
  • Impact on Clinical Trials and Drug Development
  • Government Initiatives

5. Global Brain Cancer Therapeutics Market, By Indication, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Glioblastoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Meningioma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Pituitary Tumors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Brain Cancer Therapeutics Market, By Treatment Type, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Targeted Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Chemotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Immunotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Brain Cancer Therapeutics Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Brain Cancer Therapeutics Market, By Region, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2028
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Region/Countries, 2017 - 2028, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • AstraZeneca PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • F. Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • GlaxoSmithKline PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Merck & Co
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Bristol-Myers Squibb Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us